157 related articles for article (PubMed ID: 31193160)
1. Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study.
Pathania YS; Bishnoi A; Parsad D; Kumar A; Kumaran MS
World Allergy Organ J; 2019; 12(5):100033. PubMed ID: 31193160
[TBL] [Abstract][Full Text] [Related]
2. Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
Bei W; Qian J; Zilu Q; Kai C; Ruili J; Feng H; Liuqing C
Int Immunopharmacol; 2023 Oct; 123():110577. PubMed ID: 37567010
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
Ghazanfar MN; Holm JG; Thomsen SF
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.
Nettis E; Cegolon L; Di Leo E; Lodi Rizzini F; Detoraki A; Canonica GW;
Ann Allergy Asthma Immunol; 2018 Oct; 121(4):474-478. PubMed ID: 29949781
[TBL] [Abstract][Full Text] [Related]
5. Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria.
Boonpiyathad T; Sangasapaviliya A
Asia Pac Allergy; 2016 Oct; 6(4):226-235. PubMed ID: 27803883
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
[TBL] [Abstract][Full Text] [Related]
7. Fenebrutinib in H
Metz M; Sussman G; Gagnon R; Staubach P; Tanus T; Yang WH; Lim JJ; Clarke HJ; Galanter J; Chinn LW; Chu T; Teterina A; Burgess T; Haddon DJ; Lu TT; Maurer M
Nat Med; 2021 Nov; 27(11):1961-1969. PubMed ID: 34750553
[TBL] [Abstract][Full Text] [Related]
8. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial.
Atefi N; Fallahpour M; Sharifi S; Ghassemi M; Roohaninasab M; Goodarzi A
Eur Ann Allergy Clin Immunol; 2022 May; 54(3):123-130. PubMed ID: 33939347
[No Abstract] [Full Text] [Related]
9. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Autologous Serum Therapy in Chronic Spontaneous Urticaria in the Pediatric Population: A Prospective Pilot Study.
Agarwal A; Jena AK; Dash M; Panda M
Indian Dermatol Online J; 2023; 14(2):195-199. PubMed ID: 37089855
[TBL] [Abstract][Full Text] [Related]
11. Bilastine in Refractory Chronic Spontaneous Urticaria: Disease Control and Cytokine Modulation in an Open-label Prospective Study.
De A; Singh S; Chakraborty D; Sarda A; Godse K
Indian J Dermatol; 2024; 69(2):132-136. PubMed ID: 38841225
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
[No Abstract] [Full Text] [Related]
13. Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
Mandel VD; Guanti MB; Liberati S; Demonte A; Pellacani G; Pepe P
Dermatol Ther (Heidelb); 2018 Jun; 8(2):291-301. PubMed ID: 29770909
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
Podder I; Das A; Ghosh S; Biswas D; Sengupta S; Chowdhury SN
Dermatol Ther; 2020 Nov; 33(6):e13946. PubMed ID: 32618048
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Acupuncture for Chronic Spontaneous Urticaria : A Randomized Controlled Trial.
Zheng H; Xiao XJ; Shi YZ; Zhang LX; Cao W; Zheng QH; Zhong F; Hao PS; Huang Y; Chen ML; Zhang W; Zhou SY; Wang YJ; Wang C; Zhou L; Chen XQ; Yang ZQ; Zou ZH; Zhao L; Liang FR; Li Y
Ann Intern Med; 2023 Dec; 176(12):1617-1624. PubMed ID: 37956431
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
18. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria.
Yu L; Buttgereit T; Stahl Skov P; Schmetzer O; Scheffel J; Kocatürk E; Zawar V; Magerl M; Maurer M
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1747-1754. PubMed ID: 31025425
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Autologous Serum Therapy in Chronic Spontaneous Urticaria Depends on Autologous Serum Skin Test Positivity.
Elazab SZ; Hessam WF
Egypt J Immunol; 2017 Jun; 24(2):165-172. PubMed ID: 29528589
[TBL] [Abstract][Full Text] [Related]
20. The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria.
Magen E; Zueva E; Mishal J; Schlesinger M
Allergy Asthma Proc; 2016 Sep; 37(5):394-9. PubMed ID: 27657523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
